查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621593

人造血管市场：按原料、产品、应用和最终用户划分 - 全球预测 2025-2030

Vascular Graft Market by Raw Material (Biological Materials, Polyester, Polytetrafluoroethylene), Product (Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血管移植市值为35.1亿美元，预计2024年将达到37.7亿美元，复合年增长率为7.39%，到2030年将达到57.9亿美元。

血管移植物是医疗设备，用于替换、绕过或修復因疾病或创伤而受损的部分血管。该市场包括合成血管移植物、生物血管移植物和生物合成血管移植物，其应用广泛，如冠状动脉绕道手术、血液透析机通路和周边动脉疾病。血管移植物的需求主要是由于心血管疾病盛行率不断上升、需要透析的终末期肾臟病率不断上升以及易患血管疾病的老年人口不断增加。最终使用区域包括经常进行此类手术的医院、诊所和门诊手术中心。影响血管移植市场的主要成长要素包括移植材料的技术进步、对微创手术的日益偏好以及有利的报销方案。然而，移植手术相关的高成本、移植物破损和感染等潜在併发症以及严格的法规环境等限制因素对市场成长构成了挑战。该领域的发展机会包括开发具有增强生物相容性和抗血栓特性的下一代移植物，以及扩展到医疗基础设施投资不断增加的新兴市场。创新研究领域包括生物分解性血管移植物的研究、改进组织工程技术以及利用 3D 列印技术客製化血管移植物以适应每位患者的解剖结构。他们也可能探索与生技公司在研发方面的合作，以保持技术趋势的领先地位。血管移植市场是一个竞争激烈的市场，领先的公司投资于产品开发和策略联盟，以扩大其全球影响力。希望利用这些机会的公司将能够有效地利用法律规范，开发具有成本效益的製造工艺，简化核准和市场推出时间表，并开发满足不同手术需求的产品系列。

主要市场统计
基准年[2023] 35.1亿美元
预计年份 [2024] 37.7亿美元
预测年份 [2030] 57.9亿美元
复合年增长率（%） 7.39%

市场动态：快速发展的人工血管市场的关键市场洞察

供需的动态交互作用正在改变血管移植市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 世界各地与文明病盛行率不断上升
    • 微创手术日益偏好青睐
    • 人造血管临床试验数量增加
  • 市场限制因素
    • 人工血管手术治疗费用高
  • 市场机会
    • 改善血管移植物的设计和性能
    • 组织工程人造血管的研製
  • 市场挑战
    • 与血管移植物相关的感染疾病

波特五力：引领人工血管市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对血管移植市场的影响

外部宏观环境因素在塑造血管移植市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解人造血管市场的竞争状况

对血管移植市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵血管移植市场供应商绩效评估

FPNV定位矩阵是评估血管移植市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了血管移植市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对血管移植市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地与文明病发生率正在增加
      • 人们对微创手术的兴趣日益浓厚
      • 血管移植临床试验增加
    • 抑制因素
      • 人工血管手术治疗费用高
    • 机会
      • 改善血管移植物的设计和性能
      • 利用组织工程开发血管移植
    • 任务
      • 血管移植相关感染疾病
  • 市场区隔分析
    • 原料：聚四氟乙烯血管移植物的使用由于其生物相容性和灵活性而迅速增加。
    • 产品：增加使用周边血管移植物来恢復週边动脉阻塞患者的血流
    • 应用：血管移植物在治疗心血管疾病的重要用途
    • 最终使用者：血管移植物在门诊手术中心（ASC）的重要应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 人工血管市场：依原料分类

  • 生物材料
    • 人类隐静脉和脐静脉
    • 组织工程材料
  • 聚酯纤维
  • 聚四氟乙烯
  • 聚氨酯

第七章人工血管市场：副产品

  • 冠状动脉绕道手术手术
  • 血管内血管支架
  • 血液透析机通路移植物
  • 周边设备人工血管

第八章人造血管市场：依应用分类

  • 动脉瘤
  • 心血管
  • 糖尿病
  • 肾衰竭
  • 血管闭塞

第九章人工血管市场：依最终用户分类

  • 门诊手术中心
  • 医院

第十章北美和南美人工血管市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太人工血管市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的人工血管市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Aquedeon Medical, Inc. 的 Duett 人工血管系统获得 FDA IDE核准
    • Xeltis 的 aXess 血管移植开发获得欧洲创新理事会的资助
    • Vygon 与 Carmat 合作开发用于人工心臟的人造血管
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Affluent Medical
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOVIC Sdn. Bhd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical, Inc.
  • Corcym Srl
  • CryoLife, Inc.
  • Endologix Inc.
  • Getinge AB
  • Heart Medical Europe BV
  • Japan Lifeline Co., Ltd.
  • Lemaitre Vascular, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Perouse Medical SAS by Vygon SAS
  • Rua Life Sciences PLC
  • Shanghai Suokang Medical Implants Co. Ltd.
  • Terumo Corporation
  • Vascular Graft Solutions Ltd.
  • VUP Medical
  • WL Gore & Associates, Inc.
  • Xeltis BV
Product Code: MRR-034B50030374

The Vascular Graft Market was valued at USD 3.51 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 7.39%, to USD 5.79 billion by 2030.

Vascular grafts are medical devices used to replace, bypass, or repair sections of blood vessels that are damaged due to disease or traumatic injury. The scope of this market includes synthetic, biological, and biosynthetic vascular grafts, with applications spanning coronary artery bypass, hemodialysis access, and peripheral artery diseases. The necessity for vascular grafts is primarily driven by the rising prevalence of cardiovascular diseases, increasing incidence of end-stage renal diseases necessitating dialysis, and growing geriatric population who are more prone to vascular disorders. End-use segments include hospitals, clinics, and ambulatory surgical centers where such procedures are frequently performed. Key growth factors influencing the vascular graft market include technological advancements in graft materials, increasing preference for minimally invasive surgeries, and favorable reimbursement scenarios. However, limitations such as high costs associated with graft procedures, potential complications like graft failure or infection, and stringent regulatory environments pose challenges to market growth. Opportunities in this field include developing next-generation grafts with enhanced biocompatibility and anti-thrombogenic properties, and expanding into emerging markets with growing healthcare infrastructure investments. Innovative areas for research include exploring biodegradable vascular grafts, improving tissue engineering techniques, and leveraging 3D printing technology to tailor-make vascular grafts suited for individual patient anatomy. There is also potential in exploring collaborations with biotech firms for research and development to stay ahead of technology trends. The nature of the vascular graft market is competitive, with major players investing in product development and strategic partnerships to enhance their global presence. Businesses looking to capitalize on these opportunities should focus on cost-effective manufacturing processes, streamlining approval and launch timelines, and expanding product portfolios to meet diverse surgical needs, while navigating regulatory frameworks efficiently.

KEY MARKET STATISTICS
Base Year [2023] USD 3.51 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 5.79 billion
CAGR (%) 7.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Graft Market

The Vascular Graft Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of lifestyle-related disorders globally
    • Growing preference for minimally invasive procedures
    • Rising number of clinical trials of vascular grafts
  • Market Restraints
    • High treatment cost of vascular graft procedures
  • Market Opportunities
    • Improvements in the design and performance of vascular grafts
    • Development of tissue-engineered vascular grafts
  • Market Challenges
    • Infections associated with vascular grafts

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Graft Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Graft Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Graft Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Graft Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Graft Market

A detailed market share analysis in the Vascular Graft Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Graft Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Graft Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Graft Market

A strategic analysis of the Vascular Graft Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Graft Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn. Bhd., Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe B.V., Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., Perouse Medical SAS by Vygon SAS, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V..

Market Segmentation & Coverage

This research report categorizes the Vascular Graft Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Raw Material, market is studied across Biological Materials, Polyester, Polytetrafluoroethylene, and Polyurethane. The Biological Materials is further studied across Human Saphenous & Umbilical Veins and Tissue Engineered Materials.
  • Based on Product, market is studied across Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft, and Peripheral Vascular Graft.
  • Based on Application, market is studied across Aneurysm, Cardiovascular, Diabetes, Kidney Failure, and Vascular Occlusion.
  • Based on End-User, market is studied across Ambulatory Surgical Center and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of lifestyle-related disorders globally
      • 5.1.1.2. Growing preference for minimally invasive procedures
      • 5.1.1.3. Rising number of clinical trials of vascular grafts
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment cost of vascular graft procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in the design and performance of vascular grafts
      • 5.1.3.2. Development of tissue-engineered vascular grafts
    • 5.1.4. Challenges
      • 5.1.4.1. Infections associated with vascular grafts
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Raw Material: Burgeoning utilization of polytetrafluoroethylene-based vascular grafts owing to their biocompatibility and flexibility
    • 5.2.2. Product: Proliferating usage of peripheral vascular graft for restoring blood flow in patients with blockages in the peripheral arteries
    • 5.2.3. Application: Significant use of vascular grafts in treating cardiovascular diseases
    • 5.2.4. End-User: Significant applications of vascular grafts in ambulatory surgical centers (ASCs)
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Graft Market, by Raw Material

  • 6.1. Introduction
  • 6.2. Biological Materials
    • 6.2.1. Human Saphenous & Umbilical Veins
    • 6.2.2. Tissue Engineered Materials
  • 6.3. Polyester
  • 6.4. Polytetrafluoroethylene
  • 6.5. Polyurethane

7. Vascular Graft Market, by Product

  • 7.1. Introduction
  • 7.2. Coronary Artery By-Pass Graft
  • 7.3. Endovascular Stent Graft
  • 7.4. Hemodialysis Access Graft
  • 7.5. Peripheral Vascular Graft

8. Vascular Graft Market, by Application

  • 8.1. Introduction
  • 8.2. Aneurysm
  • 8.3. Cardiovascular
  • 8.4. Diabetes
  • 8.5. Kidney Failure
  • 8.6. Vascular Occlusion

9. Vascular Graft Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Center
  • 9.3. Hospital

10. Americas Vascular Graft Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vascular Graft Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vascular Graft Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
    • 13.3.2. Xeltis' aXess Vascular Graft Development Receives Funding From European Innovation Council
    • 13.3.3. Vygon Partners with Carmat to Develop a Vascular Graft for an Artificial Heart
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Affluent Medical
  • 3. B. Braun Melsungen AG
  • 4. Becton, Dickinson and Company
  • 5. BIOVIC Sdn. Bhd.
  • 6. Boston Scientific Corporation
  • 7. Cardinal Health Inc.
  • 8. Cook Medical, Inc.
  • 9. Corcym S.r.l.
  • 10. CryoLife, Inc.
  • 11. Endologix Inc.
  • 12. Getinge AB
  • 13. Heart Medical Europe B.V.
  • 14. Japan Lifeline Co., Ltd.
  • 15. Lemaitre Vascular, Inc.
  • 16. Medtronic PLC
  • 17. Merit Medical Systems, Inc.
  • 18. Perouse Medical SAS by Vygon SAS
  • 19. Rua Life Sciences PLC
  • 20. Shanghai Suokang Medical Implants Co. Ltd.
  • 21. Terumo Corporation
  • 22. Vascular Graft Solutions Ltd.
  • 23. VUP Medical
  • 24. W. L. Gore & Associates, Inc.
  • 25. Xeltis B.V.

LIST OF FIGURES

  • FIGURE 1. VASCULAR GRAFT MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR GRAFT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR GRAFT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR GRAFT MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HUMAN SAPHENOUS & UMBILICAL VEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY TISSUE ENGINEERED MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2023